Vital Chemtech Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 27, 2025
VITAL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vital Chemtech Limited submitted the scrutinizer's report for its 4th AGM held on September 27, 2025. All 10 resolutions were passed, including adoption of audited standalone and consolidated financial statements for FY ending March 31, 2025, re-appointment of a rotating director, ratification of cost auditor remuneration, appointment of two independent directors, change in designation of a promoter director, approval of two material related party transactions, and approval of the Vital Employee Stock Option Scheme 2025. Total voting participation was 74.62% of outstanding shares (17,871,900 votes polled out of 23,951,100 shares), with promoters (73.43% stake) voting 100% in favor on most resolutions. Promoters recused from voting on the two related party transaction resolutions. The two ESOP resolutions received 99.58% approval with a minor dissent of 1,200 votes (0.42%) from public non-institutional shareholders.
All standard AGM business cleared smoothly with no contested resolutions, indicating stable governance. The approved ESOP 2025 scheme may lead to future equity dilution, though specific grant sizes are yet to be disclosed. Material related party transactions with group entities (Vital Chemicals and Vital Synthesis) approved for FY26 signal continued inter-group business activity. Overall, neutral-to-slightly-positive signal for shareholders with no significant governance red flags.